STAAR Surgical (STAA) reported a Q4 loss late Tuesday of $0.37 per diluted share, narrowing from a loss of $0.69 a year earlier.
Analysts surveyed by FactSet expected earnings of $0.04.
Revenue for the three months ended Jan. 2 was $57.8 million, up from $49.0 million a year earlier.
Analysts polled by FactSet expected $75 million.